Path8 Study LNK CD34620

Path8 Study LNK CD34620

We are recruiting at our Lincoln, NE location for our 'Path8' clinical study that pays up to $7,150 for time & commitment.

CD34620 Requirements Include:
• Males & Females of Non-Childbearing Potential
• Ages: 19-55
• BMI: 18.00-32.00

About the Clinical Study
Stipend: $7,150
Length: One - 14 Night Stay & 1 Return
• This investigational medication is being developed to treat Cystic Fibrosis.

Study Schedule - Subject to Change
• Study Start: 4/24/2022
• Screening Date: 4/19/2022
• Screening Date: 4/21/2022
• Screening Date: 4/22/2022

Learn more

Fill out the form to receive a phone call within 24 hours from a Celerion Study Participant Representative.


Want to talk to a rep?
Study Participant Representatives at our Customer-Care-Center are available to answer questions.
1-866-445-7033
(United States Toll Free)

Want to learn more about Clinical Trials: 
From the Food and Drug Administration (FDA) 

Why Healthy Subjects - Explainer Video

Celerion - Help Research - COVID Safety

Please enter Numbers only.
Please enter Numbers only.
Choose your gender at birth.